Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MSTN contributors: mct/pgu - updated : 18-01-2015
HGNC name myostatin
HGNC id 4223
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional germinal mutation      
in gross muscle hypertrophy
constitutional       loss of function
results in increased muscle mass
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
neuromuscularmyopathy 
myostatin inhibitors have entered clinical trials in patients with muscle wasting and degenerative diseases; inhibitors have the potential of increasing muscle regeneration through the effects of myostatin on myoblasts and also of inhibiting fibrosis th
cardiovascularaquired 
targeted inhibition of myostatin in cardiac cachexia might be a therapeutic option in the future
obesity  
. increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes
diabete  
. increasing muscle mass by administration of myostatin antagonists may be a promising therapeutic target for treating patients with obesity or diabetes
diabete  
altering the final stages of adipogenesis through targeted GDF8 exposure, may have therapeutic benefit in metabolic disaeses such as diabetes
cancer  
MSTN inhibition is a potential therapy for muscle wasting diseases, some of which are associated with a depletion of satellite cells
ANIMAL & CELL MODELS
  • myostatin knockout in mice increases myogenesis and decreases adipogenesis
  • Mstn(-/-) mice have a dramatic increase in muscle mass, reduction in fat mass, and resistance to diet-induced and genetic obesity
  • Mstn-deficient animals result in an increase of skeletal muscle mass with both hyperplasia and hypertrophy
  • Mstn-null mice exhibited delayed skin wound healing attributable to a combination of effects resulting from delayed epidermal reepithelialization and dermal contraction